pubmed-article:12001116 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12001116 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:12001116 | lifeskim:mentions | umls-concept:C0476089 | lld:lifeskim |
pubmed-article:12001116 | lifeskim:mentions | umls-concept:C0027627 | lld:lifeskim |
pubmed-article:12001116 | lifeskim:mentions | umls-concept:C0694888 | lld:lifeskim |
pubmed-article:12001116 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
pubmed-article:12001116 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:12001116 | lifeskim:mentions | umls-concept:C1517945 | lld:lifeskim |
pubmed-article:12001116 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:12001116 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:12001116 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:12001116 | pubmed:dateCreated | 2002-5-23 | lld:pubmed |
pubmed-article:12001116 | pubmed:abstractText | The PTEN tumor suppressor gene frequently is involved in endometrial carcinoma. Loss of heterozygosity and mutations reportedly are common, although the biologic importance of these changes remain largely unknown. The objective of this study was to assess the pattern of PTEN expression by immunohistochemistry in a large series of patients with endometrial carcinoma. | lld:pubmed |
pubmed-article:12001116 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12001116 | pubmed:language | eng | lld:pubmed |
pubmed-article:12001116 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12001116 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:12001116 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12001116 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12001116 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12001116 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12001116 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12001116 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12001116 | pubmed:month | Apr | lld:pubmed |
pubmed-article:12001116 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:12001116 | pubmed:author | pubmed-author:DasSomaS | lld:pubmed |
pubmed-article:12001116 | pubmed:author | pubmed-author:StefanssonIng... | lld:pubmed |
pubmed-article:12001116 | pubmed:author | pubmed-author:AkslenLars... | lld:pubmed |
pubmed-article:12001116 | pubmed:author | pubmed-author:SalvesenHelga... | lld:pubmed |
pubmed-article:12001116 | pubmed:author | pubmed-author:KalvenesMay... | lld:pubmed |
pubmed-article:12001116 | pubmed:copyrightInfo | Copyright 2002 American Cancer Society. | lld:pubmed |
pubmed-article:12001116 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12001116 | pubmed:day | 15 | lld:pubmed |
pubmed-article:12001116 | pubmed:volume | 94 | lld:pubmed |
pubmed-article:12001116 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12001116 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12001116 | pubmed:pagination | 2185-91 | lld:pubmed |
pubmed-article:12001116 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:meshHeading | pubmed-meshheading:12001116... | lld:pubmed |
pubmed-article:12001116 | pubmed:year | 2002 | lld:pubmed |
pubmed-article:12001116 | pubmed:articleTitle | Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. | lld:pubmed |
pubmed-article:12001116 | pubmed:affiliation | Department of Pathology, The Gade Institute, Haukeland University Hospital, Bergen, Norway. salvesen@haukeland.no | lld:pubmed |
pubmed-article:12001116 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12001116 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:12001116 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12001116 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12001116 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12001116 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12001116 | lld:pubmed |